IC-307 Preoperative Massive Biofilm and MGD Management Boosts Refractive Cataract Adoption Over Traditional Lens Surgery | ASCRS
Session
IC-307 Preoperative Massive Biofilm and MGD Management Boosts Refractive Cataract Adoption Over Traditional Lens Surgery
April 2024
Meeting: 2024 ASCRS Annual Meeting
Course Instructor: Matteo Piovella, MD
Co-Instructors: Barbara Kusa, MD; Eric D. Donnenfeld, MD, FACS; Roger Zaldivar, MD, MBA, MSc; Cynthia Matossian, MD, FACS; Marguerite B. McDonald, MD, FACS
This content is only available to 2024 ASCRS Annual Meeting physician registrants

To log in, click the teal "Login" button in the upper right-hand corner of this page. If you are logged in but still do not have access, please check your 2024 Annual Meeting registration.

Course Description
Course will certify as precise IOL power detection is based on advanced multiple biometry exams and smooth cornea surface.The MAPRY clear oil protocol is based on three consecutive treatments. First applied is Blephex(LLC) to remove Demodex and biofilm.LipiFlow (J&J)replaces occlusions of the MG into the liquid state. ILux (Alcon)expels from the meibomian glands the substances responsible for their obstruction one session per month for 5 months

Educational Objective
The clear oil protocol before biometry provides good refractive outcomes

2024 ASCRS Annual Meeting Instructional Courses

This 1.5 hour Instructional Course was recorded at the 2024 ASCRS Annual Meeting in Boston, Massachusetts, April 5-8, 2024. 

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.